Cargando…
Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats
Diabetic nephropathy results in end-stage renal disease. On the other hand, carvedilol has been reported to have various pharmacological properties. The aim of this study therefore is to evaluate the possible protective effect of carvedilol on streptozotocin-induced early diabetic nephropathy and va...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065664/ https://www.ncbi.nlm.nih.gov/pubmed/24991534 http://dx.doi.org/10.1155/2014/105214 |
_version_ | 1782322119132053504 |
---|---|
author | Morsy, Mohamed A. Ibrahim, Salwa A. Amin, Entesar F. Kamel, Maha Y. Abdelwahab, Soha A. Hassan, Magdy K. |
author_facet | Morsy, Mohamed A. Ibrahim, Salwa A. Amin, Entesar F. Kamel, Maha Y. Abdelwahab, Soha A. Hassan, Magdy K. |
author_sort | Morsy, Mohamed A. |
collection | PubMed |
description | Diabetic nephropathy results in end-stage renal disease. On the other hand, carvedilol has been reported to have various pharmacological properties. The aim of this study therefore is to evaluate the possible protective effect of carvedilol on streptozotocin-induced early diabetic nephropathy and various mechanisms underlie this effect in rats. Single i.p. injection of streptozotocin (65 mg/kg) was administered to induce early diabetic nephropathy in Wistar rats. Oral administration of carvedilol at a dose level of 1 and 10 mg/kg daily for 4 weeks resulted in nephroprotective effect as evident by significant decrease in serum creatinine level, urinary albumin/creatinine ratio, and kidney index as well as renal levels of malondialdehyde, nitric oxide, tumor necrosis factor-α, and cyclooxygenase-2 with a concurrent increase in creatinine clearance and renal reduced glutathione level compared to diabetic untreated rats. The protective effect of carvedilol was confirmed by renal histopathological examination. The electron microscopic examination indicated that carvedilol could effectively ameliorate glomerular basement membrane thickening and podocyte injury. In conclusion, carvedilol protects rats against streptozotocin-induced early diabetic nephropathy possibly, in part, through its antioxidant as well as anti-inflammatory activities, and ameliorating podocyte injury. |
format | Online Article Text |
id | pubmed-4065664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40656642014-07-02 Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats Morsy, Mohamed A. Ibrahim, Salwa A. Amin, Entesar F. Kamel, Maha Y. Abdelwahab, Soha A. Hassan, Magdy K. Biomed Res Int Research Article Diabetic nephropathy results in end-stage renal disease. On the other hand, carvedilol has been reported to have various pharmacological properties. The aim of this study therefore is to evaluate the possible protective effect of carvedilol on streptozotocin-induced early diabetic nephropathy and various mechanisms underlie this effect in rats. Single i.p. injection of streptozotocin (65 mg/kg) was administered to induce early diabetic nephropathy in Wistar rats. Oral administration of carvedilol at a dose level of 1 and 10 mg/kg daily for 4 weeks resulted in nephroprotective effect as evident by significant decrease in serum creatinine level, urinary albumin/creatinine ratio, and kidney index as well as renal levels of malondialdehyde, nitric oxide, tumor necrosis factor-α, and cyclooxygenase-2 with a concurrent increase in creatinine clearance and renal reduced glutathione level compared to diabetic untreated rats. The protective effect of carvedilol was confirmed by renal histopathological examination. The electron microscopic examination indicated that carvedilol could effectively ameliorate glomerular basement membrane thickening and podocyte injury. In conclusion, carvedilol protects rats against streptozotocin-induced early diabetic nephropathy possibly, in part, through its antioxidant as well as anti-inflammatory activities, and ameliorating podocyte injury. Hindawi Publishing Corporation 2014 2014-06-04 /pmc/articles/PMC4065664/ /pubmed/24991534 http://dx.doi.org/10.1155/2014/105214 Text en Copyright © 2014 Mohamed A. Morsy et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Morsy, Mohamed A. Ibrahim, Salwa A. Amin, Entesar F. Kamel, Maha Y. Abdelwahab, Soha A. Hassan, Magdy K. Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats |
title | Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats |
title_full | Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats |
title_fullStr | Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats |
title_full_unstemmed | Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats |
title_short | Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats |
title_sort | carvedilol ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065664/ https://www.ncbi.nlm.nih.gov/pubmed/24991534 http://dx.doi.org/10.1155/2014/105214 |
work_keys_str_mv | AT morsymohameda carvedilolamelioratesearlydiabeticnephropathyinstreptozotocininduceddiabeticrats AT ibrahimsalwaa carvedilolamelioratesearlydiabeticnephropathyinstreptozotocininduceddiabeticrats AT aminentesarf carvedilolamelioratesearlydiabeticnephropathyinstreptozotocininduceddiabeticrats AT kamelmahay carvedilolamelioratesearlydiabeticnephropathyinstreptozotocininduceddiabeticrats AT abdelwahabsohaa carvedilolamelioratesearlydiabeticnephropathyinstreptozotocininduceddiabeticrats AT hassanmagdyk carvedilolamelioratesearlydiabeticnephropathyinstreptozotocininduceddiabeticrats |